These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
6. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574 [TBL] [Abstract][Full Text] [Related]
7. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345 [TBL] [Abstract][Full Text] [Related]
8. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048 [TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance. Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196 [TBL] [Abstract][Full Text] [Related]
11. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211 [TBL] [Abstract][Full Text] [Related]
12. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Zhang XY; Zhou DF; Cao LY; Wu GY Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395 [TBL] [Abstract][Full Text] [Related]
13. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial. Takahashi H; Kamata M; Yoshida K; Ishigooka J; Higuchi H J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937 [TBL] [Abstract][Full Text] [Related]
15. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426 [TBL] [Abstract][Full Text] [Related]
16. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. Kinon BJ; Roychowdhury SM; Milton DR; Hill AL J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine. Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M; Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763 [TBL] [Abstract][Full Text] [Related]